[{"NetIncomeLoss_1_Q3_USD":-24024000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":45.26,"DepreciationAndAmortization_3_Q3_USD":2528000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":24180000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8477000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":17695000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":48.75,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-264000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":17654000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":608000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":49337000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-35692000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":1479000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":855000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":152000.0,"AssetsCurrent_0_Q3_USD":321155000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6468000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":4322000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":686000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":272974000.0,"UnrecognizedTaxBenefits_0_Q3_USD":529000.0,"CommonStockSharesIssued_0_Q3_shares":20211000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":367929000.0,"Assets_0_Q3_USD":450436000.0,"ShareBasedCompensation_3_Q3_USD":15638000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5917000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":67.27,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-319000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":345000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-1108000.0,"Liabilities_0_Q3_USD":32586000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":46994000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":48.75,"EarningsPerShareBasic_3_Q3_USD":-2.7,"EarningsPerShareBasic_1_Q3_USD":-1.19,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":20155000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":20201000.0,"AssetsFairValueDisclosure_0_Q3_USD":369616000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":3671000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1661000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":439000.0,"AccountsReceivableNetCurrent_0_Q3_USD":21624000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-19788000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-9384000.0,"CommonStockValue_0_Q3_USD":202000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":115706000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q3_USD":529000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":2137000.0,"CostsAndExpenses_3_Q3_USD":149345000.0,"CostsAndExpenses_1_Q3_USD":55471000.0,"AssetRetirementObligationsNoncurrent_0_Q3_USD":317000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-55505000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-24343000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":195000.0,"OtherAssetsNoncurrent_0_Q3_USD":92000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":4601000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1637000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":344737000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":-232000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":125165000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":3876000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-1108000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-319000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":273000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-74185000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-33408000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":534000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5475000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-48975000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":20155000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":20201000.0,"LiabilitiesCurrent_0_Q3_USD":28624000.0,"AccountsPayableCurrent_0_Q3_USD":5895000.0,"NonoperatingIncomeExpense_3_Q3_USD":1661000.0,"NonoperatingIncomeExpense_1_Q3_USD":439000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":12137000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2671000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1055000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":17654000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":5209000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":102000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":16000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q3_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":17312000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6613000.0,"NetIncomeLoss_3_Q3_USD":-54397000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":307949000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1518000.0,"EarningsPerShareDiluted_1_Q3_USD":-1.19,"CommonStockSharesOutstanding_0_Q3_shares":20211000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":73499000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":21624000.0,"OperatingIncomeLoss_3_Q3_USD":-75846000.0,"OperatingIncomeLoss_1_Q3_USD":-33847000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":252223000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":17529000.0,"IncomeTaxReceivable_0_Q3_USD":30570000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":44.95,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":26.08,"LiabilitiesAndStockholdersEquity_0_Q3_USD":450436000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":4363000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":15638000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5475000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":139000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":5034000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":3057000.0,"ProfitLoss_3_Q3_USD":-54397000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":846000.0,"StockholdersEquity_0_Q3_USD":417850000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":717000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":367808000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1516000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3876000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2418000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":73175000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-82530000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-1868000.0,"EarningsPerShareDiluted_3_Q3_USD":-2.7,"AccruedProfessionalFeesCurrent_0_Q3_USD":697000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]